Intelligence ยท Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors โ phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ searchable for business development and competitive intelligence.
-
Traumastemยฎ
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Liver Hemorrhage
1 trial -
Treatment of TongBi Capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Knee Osteoarthritis
1 trial -
Trichosanthes root
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetes Mellitus
1 trial -
Triplitode
Xiyuan Hospital of China Academy of Chinese Medical Sciences
AIDS/HIV PROBLEM
1 trial -
Unified protocol for adolescents (UP-A)
Chinese University of Hong Kong
Depressive Disorder
1 trial -
VATS
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
Venetoclax
Xiyuan Hospital of China Academy of Chinese Medical Sciences
AML
2 trials -
Venetoclax
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Lymphoblastic Leukemia
1 trial -
Ventoclax
Xiyuan Hospital of China Academy of Chinese Medical Sciences
AML (Acute Myelogenous Leukemia)
1 trial -
Venues-P Valve
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pulmonary Regurgitation
1 trial -
Verum acupuncture
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer
1 trial -
Vincristine Sulfate Liposome
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Adult Acute Lymphoblastic Leukemia
1 trial -
Wumeiwan Jiawei Fang
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Dry Eye Syndromes
1 trial -
Xiang-Sha-Liu-Jun-Zi-Tang
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Irritable Bowel Syndrome
1 trial -
YiQiFang
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cancer
2 trials -
Yinhu Qingwen Granula
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
a compound glutamine capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Mucositis
1 trial -
a compound glutamine capsule/a compound glutamine capsule simulated placebo
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Mucositis
1 trial -
a patient self-reporting applet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cancer Pain
1 trial -
administering RASI (the trade name or universal name will not be stipulated) before stenting
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Carotid Stenosis
1 trial -
adoptive immunotherapy
Chinese PLA General Hospital
Hepatocellular Carcinoma
1 trial -
avatrombopag
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Thrombocytopenia
1 trial -
behavior intervention and male circumcision
Xiyuan Hospital of China Academy of Chinese Medical Sciences
HIV
1 trial -
bevacizumab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Disease Free Survival
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1โ3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources